Literature DB >> 3624126

Hypoxia inhibits abdominal expiratory nerve activity.

R F Fregosi, S L Knuth, D K Ward, D Bartlett.   

Abstract

Our purpose was to examine the influence of steady-state changes in chemical stimuli, as well as discrete peripheral chemoreceptor stimulation, on abdominal expiratory motor activity. In decerebrate, paralyzed, vagotomized, and ventilated cats that had bilateral pneumothoraces, we recorded efferent activity from a phrenic nerve and from an abdominal nerve (cranial iliohypogastric nerve, L1). All cats showed phasic expiratory abdominal nerve discharge at normocapnia [end-tidal PCO2 38 +/- 2 Torr], but small doses (2-6 mg/kg) of pentobarbital sodium markedly depressed this activity. Hyperoxic hypercapnia consistently enhanced abdominal expiratory activity and shortened the burst duration. Isocapnic hypoxia caused inhibition of abdominal nerve discharge in 11 of 13 cats. Carotid sinus nerve denervation (3 cats) exacerbated the hypoxic depression of abdominal nerve activity and depressed phrenic motor output. Stimulation of peripheral chemoreceptors with NaCN increased abdominal nerve discharge in 7 of 10 cats, although 2 cats exhibited marked inhibition. Four cats with intact neuraxis, but anesthetized with ketamine, yielded qualitatively similar results. We conclude that when cats are subjected to steady-state chemical stimuli in isolation (no interference from proprioceptive inputs), hypercapnia potentiates, but hypoxia attenuates, abdominal expiratory nerve activity. Mechanisms to explain the selective inhibition of expiratory motor activity by hypoxia are proposed, and physiological implications are discussed.

Entities:  

Mesh:

Year:  1987        PMID: 3624126     DOI: 10.1152/jappl.1987.63.1.211

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  13 in total

1.  Vestibular and cerebellar modulation of expiratory motor activities in the cat.

Authors:  Q Huang; D Zhou; W M St John
Journal:  J Physiol       Date:  1991-05       Impact factor: 5.182

2.  Respiratory muscle recruitment during selective central and peripheral chemoreceptor stimulation in awake dogs.

Authors:  K W Saupe; C A Smith; K S Henderson; J A Dempsey
Journal:  J Physiol       Date:  1992-03       Impact factor: 5.182

3.  Respiratory activity in glossopharyngeal, vagus and accessory nerves and pharyngeal constrictors in newborn rat in vitro.

Authors:  M Iizuka
Journal:  J Physiol       Date:  2001-04-15       Impact factor: 5.182

4.  The effect of anesthesia on abdominal muscle resting length and shortening in awake dogs.

Authors:  A M Leevers; J D Road
Journal:  Lung       Date:  1995       Impact factor: 2.584

Review 5.  An interdependent model of central/peripheral chemoreception: evidence and implications for ventilatory control.

Authors:  Curtis A Smith; Hubert V Forster; Grégory M Blain; Jerome A Dempsey
Journal:  Respir Physiol Neurobiol       Date:  2010-03-04       Impact factor: 1.931

6.  The hypoxic response of neurones within the in vitro mammalian respiratory network.

Authors:  J M Ramirez; U J Quellmalz; B Wilken; D W Richter
Journal:  J Physiol       Date:  1998-03-01       Impact factor: 5.182

Review 7.  Hypoxia-induced changes in neuronal network properties.

Authors:  Fernando Peña; Jan-Marino Ramirez
Journal:  Mol Neurobiol       Date:  2005-12       Impact factor: 5.590

8.  Chest wall kinematics and respiratory muscle coordinated action during hypercapnia in healthy males.

Authors:  I Romagnoli; F Gigliotti; B Lanini; R Bianchi; N Soldani; M Nerini; R Duranti; G Scano
Journal:  Eur J Appl Physiol       Date:  2004-01-21       Impact factor: 3.078

9.  Response of the medullary respiratory network of the cat to hypoxia.

Authors:  D W Richter; A Bischoff; K Anders; M Bellingham; U Windhorst
Journal:  J Physiol       Date:  1991-11       Impact factor: 5.182

10.  GABAA and glycine receptors in regulation of intercostal and abdominal expiratory activity in vitro in neonatal rat.

Authors:  Makito Iizuka
Journal:  J Physiol       Date:  2003-08-08       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.